The Korea Electronics Technology Institute (KETI) has succeeded in developing a high sensitive bio sensor diagnosing osteoporosis on November 24. The sensor, which was co-developed by Sungkyungkwan University, can diagnose osteoporosis by detecting and quantitating parathyroid hormone (PTH), the main index to confirm osteoporosis. It is able to detect signals of regions, which were hard to detect before, by amplifying electric signals with molybdendisulphide and graphene technology.
The new sensor has improved the accuracy and safety by using nanoscale composite and minimized the size by simplifying the structure with an integrated circuit design system rather than using optical components. Since it can automate the process, it can also reduce examination costs as well as the examination time to less than 20 minutes.
The product equipped with the sensor received a good manufacturing practices (GMP)from the National Institute of Food and Drug Safety Evaluation (NIFDS) and its diagnosis cartridge is currently waiting for the second-level permission from the NIFDS.
Lee Min-ho, head of the human care system research center at the KETI which developed the technology, said, “Due to the high credibility and mass productivity, the new bio sensor platform has a global competitiveness. We will seek out domestic firms which has competence in commercialization and jointly push into the global bio sensor market that is dominated by foreign firms.”